掃碼下載
BTC $78,969.73 +4.17%
ETH $2,403.69 +3.51%
BNB $645.80 +2.42%
XRP $1.45 +1.20%
SOL $87.78 +2.59%
TRX $0.3290 -1.19%
DOGE $0.0969 +2.44%
ADA $0.2532 +2.45%
BCH $464.41 +4.41%
LINK $9.44 +0.82%
HYPE $41.18 +4.99%
AAVE $94.43 +3.25%
SUI $0.9644 +2.59%
XLM $0.1789 +0.36%
ZEC $324.02 +3.34%
BTC $78,969.73 +4.17%
ETH $2,403.69 +3.51%
BNB $645.80 +2.42%
XRP $1.45 +1.20%
SOL $87.78 +2.59%
TRX $0.3290 -1.19%
DOGE $0.0969 +2.44%
ADA $0.2532 +2.45%
BCH $464.41 +4.41%
LINK $9.44 +0.82%
HYPE $41.18 +4.99%
AAVE $94.43 +3.25%
SUI $0.9644 +2.59%
XLM $0.1789 +0.36%
ZEC $324.02 +3.34%

彭博社:Arthur Hayes 近期重金投資某人類壽命延長公司,過去 1 年定期接受幹細胞靜脈輸注治療

2025-08-21 09:43:07
收藏

ChainCatcher 消息,据彭博社報導,BitMEX 聯合創始人 Arthur Hayes 正將投資目光轉向人類壽命延長領域,其近期重金投資了一家在墨西哥和曼谷設有診所的幹細胞企業,並加入其董事會。

過去一年他定期乘機前往接受靜脈輸注治療,直言"希望儘可能健康地延長壽命"。儘管因品牌重塑暫未透露公司名稱,但他強調:這是未來趨勢------越來越多國家正放寬幹細胞使用法規。

app_icon
ChainCatcher 與創新者共建Web3世界